Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
anxiety
addiction
heart disease
liver disease
European regulators find no evidence of link between new obesity medicines and suicidal thoughts
Stat
Fri, 04/12/24 - 11:09 am
Novo Nordisk
Ozempic
Wegovy
EMA
obesity
weight loss
suicide
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wed, 04/10/24 - 09:48 am
Novo Nordisk
Ozempic
Victoza
GLP-1 agonist
thyroid cancer
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Novo Nordisk pushes back after price gouging accusations by Bernie Sanders
Biopharma Reporter
Thu, 04/4/24 - 10:55 am
Novo Nordisk
Wegovy
Ozempic
Bernie Sanders
drug pricing
Drugmaker seeks approval for China's first biosimilar Ozempic
Reuters
Wed, 04/3/24 - 11:07 am
Novo Nordisk
Ozempic
China
biosimilars
Hangzhou Jiuyuan Gene Engineering
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
BioSpace
Thu, 03/28/24 - 11:22 am
Novo Nordisk
Bernie Sanders
Ozempic
Wegovy
drug pricing
obesity
diabetes
Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds
Stat
Thu, 03/28/24 - 11:19 am
Ozempic
obesity
diabetes
Novo Nordisk
aspiration pneumonia
Eli Lilly
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
Medical Marketing and Media
Wed, 03/20/24 - 09:43 pm
GLP-1 agonist
PD-1 inhibitors
Wegovy
Ozempic
Zepbound
Mounjaro
How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients
Biopharma Reporter
Wed, 03/13/24 - 11:16 am
Ozempic
Novo Nordisk
GLP-1
diabetes
drug shortages
Novo Nordisk working with global authorities to take down fake Ozempic
Beckers Hospital Review
Mon, 03/11/24 - 05:03 pm
Novo Nordisk
drug counterfeiting
Ozempic
Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Reuters
Tue, 03/5/24 - 11:52 am
Novo Nordisk
Ozempic
clinical trials
diabetes
chronic kidney disease
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Motley Fool
Sun, 03/3/24 - 09:48 pm
Ozempic
Abbott Labs
Medtech
diabetes
CGMs
Americans don't think weight-loss drugs will fix the obesity epidemic
Axios
Wed, 02/28/24 - 10:44 am
obesity
weight loss
Ozempic
Wegovy
Zepbound
GLP-1 agonist
Novo Nordisk and Catalent deal: net positive or negative for industry?
Biopharma Reporter
Tue, 02/20/24 - 11:06 am
Novo Nordisk
Catalent
M&A
Wegovy
Ozempic
Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice
Quartz
Thu, 02/15/24 - 07:20 pm
Novo Nordisk
Lars Fruergaard Jorgensen
Ozempic
Wegovy
weight loss
Weight-loss drugs tied to benefit after hip replacement
Reuters
Mon, 02/12/24 - 10:26 am
hip replacements
GLP-1 agonist
Ozempic
Novo Nordisk
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
depression
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
obesity
weight loss
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
CNBC
Mon, 02/5/24 - 10:10 am
Novo Nordisk
Catalent
drug manufacturing
M&A
Wegovy
Ozempic
Pages
1
2
3
4
5
6
7
next ›
last »